Currently enrolling studies:
Four Repeat Tauopathy Neuroimaging Initiative (4RTNI-2)
- This study is investigating the best method of analysis to track patients with corticobasal syndrome, corticobasal degeneration, progressive supranuclear palsy, and oligo- or variant-progressive supranuclear palsy. The results will provide information about the value of novel imaging techniques for diagnosis and value of novel imaging techniques in comparison to biofluid biomarkers.
- The study will collect detailed clinical information, biofluids, and imaging data from individuals with corticobasal degeneration and progressive supranuclear palsy. There will be one visit every six months for a year (a total of three visits over one year). Oligo- or variant- progressive supranuclear palsy, and healthy participants will be asked for an additional visit approximately one year after the third visit (adding up to four visits over two years). A study partner/caregiver is required.
- You can find more information on: https://clinicaltrials.gov/ct2/show/NCT02966145
For further information about this and other studies, please contact Aishwarya Niraula by email firstname.lastname@example.org or phone 858-246-3190.